Literature DB >> 15273074

Anticancer activities of Oldenlandia diffusa.

Salin Gupta1, David Zhang, Jizu Yi, Jun Shao.   

Abstract

OBJECTIVES: To investigate the anticancer activities of a Chinese herb, Oldenlandia diffusa (Bai Hua She She Cao).
METHODS: The water extract of the raw herb Oldenlandia diffusa was used in this study. The in vitro anti-proliferative activities of the extract were tested against eight cancer cell lines and one normal cell line. Microscopic examination and DNA ladder analysis were carried out to determine the pro-apoptotic effect of the extract. In vivo studies were carried out to examine the anticancer activities of the extract using C57BL/6j mice bearing B16-F10 lung metastasis. Oldenlandia diffusa extract was given at the dose level of 5 g raw material/kg on Days 3-12 by oral gavage and the extent of lung metastases were examined on Day 14.
RESULTS: The extract exhibited a strong antiproliferative activity against all cancer cell lines tested. The concentrations of growth inhibition at 50% (IC(50)) ranged from 7 to 25 mg raw material/ml after 48-hour treatment. The extract had a very limited cytotoxicity (10% inhibition) on the normal pancreatic cells even at the concentration of 50 mg/mL. Apoptosis in B16-F10 cells after treatment with the extract was observed by microscopic examination and DNA ladder assays. Oral administration of the herbal extract effectively reduced B16-F10 cell growth in the lungs of C57Bl/j mice with a 70% reduction in lung metastases (p < 0.001).
CONCLUSIONS: Oldenlandia diffusa extract effectively inhibited the growth of all the eight cancer cell lines and induced significant increase of apoptosis. The extract exhibited minimum toxic effect on normal pancreatic cells. Furthermore, there was a significant inhibition of lung metastases in the animal model with no noticeable adverse effects. The herb extract could be a potential anticancer agent.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15273074

Source DB:  PubMed          Journal:  J Herb Pharmacother        ISSN: 1522-8940


  18 in total

1.  Mechanism of Hedyotis Diffusa in the Treatment of Cervical Cancer.

Authors:  Kai Qian; Dan Fu; Baorui Jiang; Yue Wang; Fei Tian; Li Song; Lei Li
Journal:  Front Pharmacol       Date:  2021-12-15       Impact factor: 5.810

2.  Inhibition of metastasis, angiogenesis, and tumor growth by Chinese herbal cocktail Tien-Hsien Liquid.

Authors:  Jean-San Chia; Jia-Ling Du; Wei-Bin Hsu; Andy Sun; Chun-Pin Chiang; Won-Bo Wang
Journal:  BMC Cancer       Date:  2010-04-30       Impact factor: 4.430

Review 3.  The efficacy of Chinese herbal medicine as an adjunctive therapy for advanced non-small cell lung cancer: a systematic review and meta-analysis.

Authors:  Shi Guang Li; Hai Yong Chen; Chen Sheng Ou-Yang; Xi-Xin Wang; Zhen-Jiang Yang; Yao Tong; William C S Cho
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

4.  In Vitro Anticancer Activity of the Root, Stem and Leaves of Withania Somnifera against Various Human Cancer Cell Lines.

Authors:  B Yadav; A Bajaj; M Saxena; A K Saxena
Journal:  Indian J Pharm Sci       Date:  2010-09       Impact factor: 0.975

5.  Novel PI3K/AKT targeting anti-angiogenic activities of 4-vinylphenol, a new therapeutic potential of a well-known styrene metabolite.

Authors:  Grace Gar-Lee Yue; Julia Kin-Ming Lee; Hin-Fai Kwok; Ling Cheng; Eric Chun-Wai Wong; Lei Jiang; Hua Yu; Hoi-Wing Leung; Yuk-Lau Wong; Ping-Chung Leung; Kwok-Pui Fung; Clara Bik-San Lau
Journal:  Sci Rep       Date:  2015-06-08       Impact factor: 4.379

6.  Determination of Oleanolic and Ursolic Acids in Hedyotis diffusa Using Hyphenated Ultrasound-Assisted Supercritical Carbon Dioxide Extraction and Chromatography.

Authors:  Ming-Chi Wei; Yu-Chiao Yang; Show-Jen Hong
Journal:  Evid Based Complement Alternat Med       Date:  2015-05-18       Impact factor: 2.629

7.  Mitigation of Aflatoxin B1 Hepatoxicity by Dietary Hedyotis diffusa Is Associated with Activation of NRF2/ARE Signaling in Chicks.

Authors:  Ling Zhao; Jiang Deng; Zi-Jian Xu; Wan-Po Zhang; Mahmoud Mohamed Khalil; Niel Alexander Karrow; Lv-Hui Sun
Journal:  Antioxidants (Basel)       Date:  2021-05-30

Review 8.  Cytochrome P450 enzyme mediated herbal drug interactions (Part 2).

Authors:  Sompon Wanwimolruk; Kamonrat Phopin; Virapong Prachayasittikul
Journal:  EXCLI J       Date:  2014-08-20       Impact factor: 4.068

9.  Evaluation of Synergetic Anticancer Activity of Berberine and Curcumin on Different Models of A549, Hep-G2, MCF-7, Jurkat, and K562 Cell Lines.

Authors:  Acharya Balakrishna; M Hemanth Kumar
Journal:  Biomed Res Int       Date:  2015-06-29       Impact factor: 3.411

10.  Application of genetic algorithm for discovery of core effective formulae in TCM clinical data.

Authors:  Ming Yang; Josiah Poon; Shaomo Wang; Lijing Jiao; Simon Poon; Lizhi Cui; Peiqi Chen; Daniel Man-Yuen Sze; Ling Xu
Journal:  Comput Math Methods Med       Date:  2013-10-30       Impact factor: 2.238

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.